Literature DB >> 25617222

Treatment of pediatric migraine.

Hope L O'Brien1, Marielle A Kabbouche, Joanne Kacperski, Andrew D Hershey.   

Abstract

OPINION STATEMENT: The diagnosis of migraine in the pediatric population is increasing as providers are becoming more familiar with recognizing the condition. Over-the-counter and migraine-specific treatment, once considered off-label, have proven to be effective, especially if given at the early onset of head pain. Mild to severe cases of migraine should be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), with triptans used alone or in combination in moderate to severe headaches unresponsive to over-the-counter therapy. Rescue medication including dihydroergotamine (DHE), a potent vasoconstrictor should be used for intractable migraines and is preferred in the hospital setting. Anti-emetics that have anti-dopaminergic properties can be helpful in patients with associated symptoms of nausea and vomiting along with headache, especially when used in combination therapy. Preventative treatment should be initiated early in patients with frequent headaches to improve headache outcomes and quality of life. Patients and families should be educated on non-pharmacologic management, such as lifestyle modification and avoidance of triggers, that can prevent progression and worsening of migraine.

Entities:  

Year:  2015        PMID: 25617222     DOI: 10.1007/s11940-014-0326-1

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  66 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Clonidine prophylaxis of childhood migraine and other vascular headache. A double blind study of 57 children;.

Authors:  M Sillanpää
Journal:  Headache       Date:  1977-03       Impact factor: 5.887

3.  One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study.

Authors:  A D Rothner; P Winner; R Nett; M Asgharnejad; A Laurenza; R Austin; M Peykamian
Journal:  Clin Ther       Date:  2000-12       Impact factor: 3.393

Review 4.  Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Authors:  D Lewis; S Ashwal; A Hershey; D Hirtz; M Yonker; S Silberstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

5.  Flunarizine v. placebo in childhood migraine. A double-blind study.

Authors:  F Sorge; E Marano
Journal:  Cephalalgia       Date:  1985-05       Impact factor: 6.292

6.  Botox treatment for migraine and chronic daily headache in adolescents.

Authors:  Valerie W Chan; E Jane McCabe; Daune L MacGregor
Journal:  J Neurosci Nurs       Date:  2009-10       Impact factor: 1.230

7.  Emergency department management of acute migraine in children in Canada: a practice variation study.

Authors:  Lawrence Richer; Lee Graham; Terry Klassen; Brian Rowe
Journal:  Headache       Date:  2007-05       Impact factor: 5.887

8.  Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

Authors:  Donald Lewis; Paul Winner; Joel Saper; Seth Ness; Elena Polverejan; Steven Wang; Caryn L Kurland; Jeff Nye; Eric Yuen; Marielle Eerdekens; Lisa Ford
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

9.  Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.

Authors:  M Coppola; D M Yealy; R A Leibold
Journal:  Ann Emerg Med       Date:  1995-11       Impact factor: 5.721

Review 10.  Overview of diagnosis and management of paediatric headache. Part II: therapeutic management.

Authors:  Cristiano Termine; Aynur Ozge; Fabio Antonaci; Sophia Natriashvili; Vincenzo Guidetti; Ciçek Wöber-Bingöl
Journal:  J Headache Pain       Date:  2010-12-18       Impact factor: 7.277

View more
  11 in total

Review 1.  Diagnosis and Treatment of Childhood Migraine.

Authors:  Kelsey Merison; Howard Jacobs
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

Review 2.  The optimal management of headaches in children and adolescents.

Authors:  Joanne Kacperski; Marielle A Kabbouche; Hope L O'Brien; Jessica L Weberding
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 3.  Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.

Authors:  János Tajti; Délia Szok; Anett Csáti; László Vécsei
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 4.  Pharmacotherapy for Persistent Posttraumatic Headaches in Children and Adolescents: A Brief Review of the Literature.

Authors:  Joanne Kacperski
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

Review 5.  Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 6.  Behavioral management of headache in children and adolescents.

Authors:  Noemi Faedda; Rita Cerutti; Paola Verdecchia; Daniele Migliorini; Marco Arruda; Vincenzo Guidetti
Journal:  J Headache Pain       Date:  2016-09-05       Impact factor: 7.277

Review 7.  Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.

Authors:  Rafia Shafqat; Yadira Flores-Montanez; Victoria Delbono; Stephanie J Nahas
Journal:  J Pain Res       Date:  2020-04-30       Impact factor: 3.133

8.  Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine.

Authors:  Pi-Chuan Fan; Ping-Hung Kuo; Ming Tatt Lee; Shu-Hui Chang; Lih-Chu Chiou
Journal:  Front Neurol       Date:  2019-01-24       Impact factor: 4.003

9.  Headache and mental disorders in a nationally representative sample of American youth.

Authors:  Rebecca Hommer; Tarannum Lateef; Jian-Ping He; Kathleen Merikangas
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-03-15       Impact factor: 4.785

10.  Pharmacological Bypass of Cockayne Syndrome B Function in Neuronal Differentiation.

Authors:  Yuming Wang; Jace Jones-Tabah; Probir Chakravarty; Aengus Stewart; Alysson Muotri; Rebecca R Laposa; Jesper Q Svejstrup
Journal:  Cell Rep       Date:  2016-03-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.